The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume 14, Issue 3, Pages 329-337
Publisher
Informa UK Limited
Online
2019-12-23
DOI
10.1080/17476348.2020.1708720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New therapeutic perspectives to manage refractory immune checkpoint-related toxicities
- (2019) Filipe Martins et al. LANCET ONCOLOGY
- Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates
- (2019) Randall Choo et al. BMC Pulmonary Medicine
- How to Make the Best Use of Immunotherapy as First-Line Treatment for Advanced/Metastatic Non–Small-Cell Lung Cancer
- (2019) Solange Peters et al. ANNALS OF ONCOLOGY
- Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors
- (2019) Jasna Metovic et al. ACTA CYTOLOGICA
- Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
- (2019) Davide Bedognetti et al. Journal for ImmunoTherapy of Cancer
- Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
- (2019) Fiorella Calabrese et al. Journal of Clinical Medicine
- Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response
- (2019) Iwona Kwiecien et al. Cancers
- Bronchoalveolar Lavage Fluid-Derived Exosomes: A Novel Role Contributing to Lung Cancer Growth
- (2019) Yibao Yang et al. Frontiers in Oncology
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC)
- (2018) Christian Rolfo et al. Journal of Thoracic Oncology
- Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
- (2018) Luka Brcic et al. VIRCHOWS ARCHIV
- Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade
- (2018) Kentaro Tanaka et al. Oncotarget
- Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities
- (2018) Karthik Suresh et al. CHEST
- The new guidelines of Papanicolaou Society of Cytopathology for respiratory specimens: Assessment of risk of malignancy and diagnostic yield in different cytological modalities
- (2018) Sule Canberk et al. DIAGNOSTIC CYTOPATHOLOGY
- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Pulmonary sarcoid-like granulomatosis induced by nivolumab
- (2016) H. Montaudié et al. BRITISH JOURNAL OF DERMATOLOGY
- CD4+/CD25 high /FoxP3+/CD127− regulatory T cells in bronchoalveolar lavage fluid of lung cancer patients
- (2016) Iwona Osińska et al. HUMAN IMMUNOLOGY
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid biopsies in lung cancer: The new ambrosia of researchers
- (2014) Christian Rolfo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer
- (2013) J. G. Aerts et al. CANCER RESEARCH
- Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
- (2012) William D. Travis et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)
- (2012) Nasrollah Erfani et al. LUNG CANCER
- Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer
- (2011) T. A. Zikos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma
- (2011) Thomas Schneider et al. Journal of Thoracic Oncology
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- T-regulatory cells in COPD or tumour environment
- (2009) J. Domagala-Kulawik et al. EUROPEAN RESPIRATORY JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started